Anti-inflammatory properties of GLP-1 agonists GLP-1 receptors exist throughout the body, not just in the pancreas and brain
All medications come from licensed 503A compounding pharmacies, and treatment is available in all 50 states without insurance requirements or membership fees
Swelling was reduced by 73.6 and 29% in the Pycnogenol and placebo group, respectively
A network meta-analysis comparing cardiovascular outcomes and mortality by GLP1-RA showed the following outcomes: MACE, cardiovascular death, death from any cause, myocardial infarction, stroke, and heart failure hospitalization 17
Unlike some treatments where breaks prevent tolerance, stopping and restarting these medications typically results in weight regain during the break period followed by renewed side effects upon restart